Curevac Covid Vaccine
- All
- News
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
"Our Covid Vaccine Triggered Immune Response In Humans": CureVac
CureVac's experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, putting the German biotech company on track to start mass testing this year as the race to end the pandemic heats up.
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
"Our Covid Vaccine Triggered Immune Response In Humans": CureVac
CureVac's experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, putting the German biotech company on track to start mass testing this year as the race to end the pandemic heats up.
